Bone and Cancer
Bone and Cancer
Bone and CancerBone and Cancer Foundation, PO Box 287452 Bone and Cancer New York, NY 10128-0025  
Toll Free: 888 862-0999 Bone and Cancer Email: bcfdn@aol.com  
Bone and Cancer

Clinical Trials

Nutropin (somatropin-rDNA origin)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved January 1996

Specific Treatments:

liquid growth hormone

Therapeutic Areas

General Information

Nutropin AQ is the liquid version of Nutropin R, which Genentech currently markets. It is a hormone that helps children grow and is used in children who do not make enough of their own growth hormone or who have kidney disease.

Side Effects

  • Skin rash, itching, or hives
  • Hip or knee pain, limping
  • Muscle pain
  • Pain where the shot is given
  • Headache
  • Weakness

Additional Information

You should not get this medicine if you have had an allergic reaction to somatropin or if you have cancer or a growing tumor.

 How To Order Publications:
  Glossary
  FAQ

Information About

Clinical Trials



 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 


  Copyright 2011 - The Bone and Cancer Foundation